Osiris Therapeutics (OSIR) Posts Q2 EPS of $0.05, Tops by 4c
Tweet Send to a FriendGet Alerts OSIR Hot Sheet
Price: $10.98 --0%
EPS Growth %: -100.0%
Financial Fact:
Total operating expenses: 5.87M
Today's EPS Names:
GASS, AAP, RMCF, More
EPS Growth %: -100.0%
Financial Fact:
Total operating expenses: 5.87M
Today's EPS Names:
GASS, AAP, RMCF, More
Trade OSIR Now!
Osiris Therapeutics, Inc. (Nasdaq: OSIR) reports Q2 EPS of $0.05, 4 cents better than the analyst estimate of $0.01. Revenue for the quarter was $10.3 million, which compares to the estimate of $10.57 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Dollar Tree, Inc. (DLTR) Tops Q1 EPS by 2c; Issues Muted Outlook
- Seaworld Ent. (SEAS) Narrows Q1 Loss to 49c/Share; Guides FY13 Revs
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
